Menu Search
Equities

EchoIQ Ltd

ECHQF:PKC

EchoIQ Ltd

Actions
  • Price (USD)0.06
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Mar 04 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

EchoIQ Limited is an Australia-based artificial intelligence (AI) and medical technology company. It uses AI-driven technology and proprietary software to improve decision-making in cardiology. The principal activity of the Company is the development of AI products for cardiovascular care. The Company operates through two segments: Echo IQ and Houston We Have Software. The Echo IQ segment is engaged in developing products and services in medical technology. The Houston We Have Software segment offers products and services across other sectors. Its EchoSolv product allows users to assess echocardiographic studies against diagnostic guidelines for structural heart conditions. EchoSolv automatically identifies patients at risk of structural heart disease. EchoSolv improves the standard clinical workflow associated with diagnosis and treatment. The first two conditions addressed by the product are Aortic Stenosis and Mitral Regurgitation.

  • Revenue in AUD (TTM)44.50k
  • Net income in AUD-5.41m
  • Incorporated2010
  • Employees--
  • Location
    EchoIQ LtdSuite 404, 309 George StreetSYDNEY 2000AustraliaAUS
  • Phone+61 29159-3719
  • Fax+61 28039-0534
  • Websitehttps://www.echoiq.ai/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.